LC/MS Analysis of Clenbuterol Enantiomers in Plasma on Astec® CHIROBIOTIC® T after SPE using HybridSPE®-Phospholipid

LC/MS Analysis of Clenbuterol Enantiomers in Plasma on Astec® CHIROBIOTIC® T after SPE using HybridSPE®-Phospholipid

Conditions

column CHIROBIOTIC T, 10 cm x 2.1 mm I.D., 5 µm particles (12018AST)
column temp. 30 °C
mobile phase 10 mM ammonium formate in methanol
flow rate 0.3 mL/min
sample clenbuterol, 10 ng/mL in rat plasma (phospholipids removed by extraction with HybridSPE-Phospholipid)
detector ESI(+)

Description

Categories Analytical Chromatography, Forensics and Toxicology, Chiral Applications, Clinical, drugs of abuse, Bronchodilators, Pharmaceutical (small molecule), Clinical, Forensic & Toxicology, bronchodilators, beta-agonists, Drugs of Abuse, All Pharmaceutical Applications
Featured Industry Clinical
Forensics and Toxicology
Pharmaceutical (small molecule)
Legal Information HybridSPE is a registered trademark of Sigma-Aldrich Co. LLC, CHIROBIOTIC is a registered trademark of Sigma-Aldrich Co. LLC, Astec is a registered trademark of Sigma-Aldrich Co. LLC
suitability application for HPLC

Materials

     
Related Links